IL33 and Sepsis: In addition, during the immunosuppressive phase of sepsis, IL-33, GM-CSF or tumor necrosis factor receptor antibody (DTA-1) administration can inhibit Treg amplification and restore Th17/Treg balance, favoring the survival of sepsis (120, 130, 173).